Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice
https://doi.org/10.15829/1728-8800-2022-3171
Abstract
The article discusses a new approach to assessing cardiovascular risk in clinical practice, presented in the European guidelines 2021. Two novel risk charts (SCORE2 and SCORE2-OP) have been proposed that have undergone significant revision and require significant changes in primary care practice. It has been suggested that in modern conditions their practical introduction is premature, since the healthcare system is not ready for renewal. Therefore, time is needed to adapt it to the practical healthcare conditions and to revise the medical screening protocols, which will require financial costs. The implementation of these recommendations should be taken responsibly so as not to harm the existing system of preventive care.
Supporting agencies: The author appreciates the Doctor of Physical and Mathematical Sciences, Professor of the Department of Probability Theory of Lomonosov Moscow State University Yarovaya E. B. for an active discussion of the work
About the Author
S. A. Shalnova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Russian Federation
Moscow
References
1. D’Agostino RB Sr, Vasan RS, Pencina MJ, et al. General Cardiovascular Risk Profile for Use in Primary Care. The Framingham Heart Study. Circulation. 2008;117(6):743-53. doi:10.1161/CIRCULATIONAHA.107699579.
2. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur H J. 2003;24:987-1003. doi: 10.1016/S0195-668X(03)00114-3.
3. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-337 doi:10.1093/eurheartj/ehab484.
4. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. doi:10.1093/eurheartj/ehw106.
5. Sedyh D, Hryachkova O, Kashtalap V. The new SCORE 2 scale: what has changed in the assessment of cardiovascular risk. Praktikuyushij kardiolog. 2021;8. (In Russ.) https://e.cardio-practice.ru/911593.
Supplementary files
Review
For citations:
Shalnova S.A. Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice. Cardiovascular Therapy and Prevention. 2022;21(1):3171. https://doi.org/10.15829/1728-8800-2022-3171
Views:
766
Email this article 
